Adherence in allergen immunotherapy: Current situation and future implications

Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Gehrt, Francesca, Xu, Qingqing, Baiardini, Ilaria, Canonica, Giorgio Walter, Pfaar, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dustri-Verlag Dr. Karl Feistle 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707370/
https://www.ncbi.nlm.nih.gov/pubmed/36457724
http://dx.doi.org/10.5414/ALX02318E
Descripción
Sumario:Allergen immunotherapy (AIT) is the only disease-modifying treatment in allergy. However clinical trials as well as real-life studies revealed poor treatment adherence. This article is intended to provide an overview of the current literature of the last 10 years, to outline reasons for poor treatment adherence in AIT and to provide possible solutions for improving adherence.

Ejemplares similares